New insulin pump drug shows promise for type 1 diabetes
NCT ID NCT06809621
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This study tested a new fast-acting insulin (NNC0471-0119) given through an insulin pump in 43 adults with type 1 diabetes. Researchers measured how quickly the insulin entered the bloodstream and lowered blood sugar, comparing it to a standard insulin (insulin aspart). The goal was to check safety and how well the new insulin works for managing diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.